HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mika Kawai-Uchida Selected Research

istradefylline

11/2015The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets.
1/2015The adenosine A2A receptor antagonist, istradefylline enhances the anti-parkinsonian activity of low doses of dopamine agonists in MPTP-treated common marmosets.
1/2014Adenosine A₂A-receptor antagonist istradefylline enhances the motor response of L-DOPA without worsening dyskinesia in MPTP-treated common marmosets.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Mika Kawai-Uchida Research Topics

Disease

3Dyskinesias (Dyskinesia)
11/2015 - 01/2014
2Parkinson Disease (Parkinson's Disease)
11/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

3istradefyllineIBA
11/2015 - 01/2014
2Carbon MonoxideIBA
11/2015 - 01/2014
2Levodopa (L Dopa)FDA LinkGeneric
11/2015 - 01/2014
1Dopamine Agonists (Dopamine Agonist)IBA
11/2015
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2015
1ropinirole (Requip)FDA LinkGeneric
01/2015
1Pergolide (Permax)FDA Link
01/2015
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2014
1AdenosineFDA LinkGeneric
01/2014